The Havanese is small in size and sturdy in structure with a tail carried over its back and ears that drop and fold. The coat is abundant, long, and silky and comes in all colors. [1] The Havanese has a spirited personality and a curious disposition, and is notable for its springy gait, a characteristic that distinguishes the breed from all others. [3] The Havanese is considered an ideal family pet and a true companion dog. [1] They are highly adaptable to almost any environment. Because of their strong social needs, Havanese will not thrive in an environment where they are isolated for several hours each day. The Havanese has dark brown eyes and almond-shaped lids surrounded by black pigment. The ears, when extended, reach half way to the nose. They arc slightly upward at the base and hang down on the sides of the head without touching the face. The tail is carried arched forward up over the back. While the tail's long plume of hair falls on the body, the tail itself never touches the back. Although there are a few arguments on whether the original Havanese were all white or of different colors, modern Havanese are acceptable in all coat colors and patterns. All colored dogs should have a black nose and black pigment around the eyes, with the exception of chocolate (brown) dogs, which may have dark brown pigment on their nose instead. Examples of coat colors are white, cream, fawn, red, chocolate brown, beige, gold, silver, blue, and black. The coat may be one solid color or have markings in one or more other colors. For example, sable, brindle, black & tan, Tri-color, Irish pied, parti colored, belton, or piebald, black and white, beige black, and white. Havanese in the "Puppy Cut" which is favored by some non-show dog owners Havanese has a cheerful nature After 10 years of attempting to convince Havanese breeders to breed away from osteochondrodysplasia. many of the original leadership of the Havanese Club of America decided to leave the organization in order to create a breed that they feel more accurately represents the original dogs from Cuba. [9] They began referring to their dogs as "Havana Silk Dogs," claiming them to be a different breed from the Havanese. However, the Havana Silk Dog is not recognized by the American Kennel Club (AKC) as separate from the Havanese, and many Havana Silk Dogs are also registered under the name "Havanese" with the AKC. The Havana Silk Dog Association of America is not currently seeking to register their breed with the AKC. The coat is shown naturally brushed out, or in some countries it may be corded. a technique which turns the long coat into cords of hair, similar to dreadlocks in humans. This corded look may be difficult to achieve for the first timer, so it is always recommended that someone interested in cording their Havanese consults someone who has done it before. Brushing out their fur is essential. This breed's fur grows very fast and without brushing it, the fur can become tangled easily. Also, even though this breed is hypoallergenic, Havanese have hair that doesn't fall off (shed) but it still needs to be groomed. Havanese puppy approximately 6 months old Havanese suffer primarily from luxating patella. liver disease, heart disease, cataracts [4] and retinal dysplasia. [4] Havanese sometimes tear and may develop brown tear stains, especially noticeable on white or light coats. Joe Pickett | Eddie Silva | James Stewart | Osvaldo Carrillo The Brewers of Ellis Island Casino and Brewery So on one hand, the extract is a traditional remedy that helps lower cholesterol. On the other, the pharmaceutical manufacturer of Mevacor argues that it owns the rights to the ingredient lovastatin. WebMD Medical Reference Reviewed by David Kiefer french quarter fest 2017, MD on October 17, 2016 Whatever the state of your health, always talk to your doctor before you start using red yeast rice or any other supplement. Remember that not all brands are equal, and that RYRE isn't safe for everyone. Though red yeast rice extract looks like a promising treatment, more research needs to be done. For now, you should be cautious. The extract may also interact with other drugs for blood pressure and thyroid problems and interact with other herbs and supplements you may be taking. However, the studies so far have been fairly small and too short to show long-term effects. Confusingly, the answer is both. One of the most important ingredients in RYRE is monacolin K. It's also known as lovastatin. the active ingredient in the prescription drug Mevacor . So even though studies have shown that RYRE can lower cholesterol, you can't really know if the supplement brand you're using will have that effect. When Scrum was first defined, it addressed a number of issues that plagued IT organizations of the 1980s. Functional silos and their key side-effect, cross-team dependencies. Lack of clear communication. Extended lead times. Poor alignment of solutions with needs. When I go in to do large scale transformations I’m invariably asked the question, “should the PMO go away?’ The reasoning is that going agile should get rid of all of the oversight, the Gantt Charts, the weekly status meetings, release scheduling. The. Change for Agile coaches is challenging, no matter how widely publicized the benefits are. Overcoming Resistance to Agile Process Roll-Outs. Jonathon Levene shares the insights he gained over years of executive coaching of cross-functional teams this week on The. Beware of mesothelioma. Oh..oh. latest medical info. Recommended way to cook this kind of red yeast rice. is by putting the rice into warm water for about 24 hours before you cook it, it makes several fungus grow, and fermentation process work well. And for other tips, is to consume all the cooked re d yeast rice for one time. If it's consumed in other time, the effect will be different. Check your serum lipid level. try your red yeast rice for 2 weeks. check it again. is it true? thx for your info, I love it :D Good day to you. Some studies showed, statistically significant reductions (16% to 31%) in total serum cholesterol compared with placebo or control or baseline. Adverse events experienced in clinical trials included stomachache, dizziness, heartburn and flatulence. No changes in laboratory tests were demonstrated. There was a case report of young man who developed anaphylaxis due to immediate sensitivity to M purpureus. Whether this is relevant to the oral administration of red yeast rice capsules is not clear. Zeng TK. Observation of the therapeutic effects of Xuezhikang for treatment of 77 elderly with hyperlipidemia. Shoudu Yiyao 1999;6(11):49. Li, C. Li, Y. Hou, Z. and et al. Experimental studies on toxicology of Xuezhikang. Communication of Chinese Pharmacological Society 1995;12(4):12. Liu, B. H. Wu, T. S. Su, M. C. Chung, C. P. and Yu, F. Y. Evaluation of citrinin occurrence and cytotoxicity in Monascus fermentation products. J Agric.Food Chem. 1-12-2005;53(1):170-175. View abstract. Patakova-Juzlova, P. Rezanka, T. and Viden, I. Identification of volatile metabolites from rice fermented by the fungus Monascus purpureus. Folia Microbiologica 1998;43:407-410. Halbert SC, French B, Gordon RY, et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol 2010;105:198-204. View abstract. Liu, Z. and Zhang, Y. Clinical observation of treatment of hyperlipidemia with Xuezhikang. Clin Med News 1996;11:12-13. Liu ZB. Xuezhikang for treatment of 40 cases of hyperlipidemia. Linchuang Huicui 1998;13(8):367-368. Chen FJ, Ruan Q Qi HW Yuan PY. Clinical observation of Xuezhikang in treating middle and old age hyperlipidemia. Shanghai Yufangyixue Zazhi 2003;15(5):222-223. Karl M, Rubenstein M, Rudnick C, Brejda J. A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability). J Clin Lipidology 2012;6:150-158. View abstract. Pisciotta, L. Boscarini, M. and Corio, R. Studi clinici su Normolip5, integratore alimentare per il controllo del colesterolo. Medicina Naturale 2004;68-70. Gong, C. Huang, S. L. Huang, J. F. Zhang, Z. F. Luo, M. Zhao, Y. and Jiang, X. J. Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence. Chin J Integr Med 2010;16(2):114-118. View abstract. Li, J. Tatsanavivat, P. Wang, J. and et al. Comparison of the efficacy and safety of xuezhikang and lovastatin in hyperlipidemic patients with hypertension [abstract]. Global Meeting ICLEN XVI, March 1999; Gu ZY, Lu ZF Zhu HQ. Observations on the therapeutic effects of Zhibituo for treatment of 158 patients with hyperlipidemia. Nantong Yixueyuan Xuebao 1998;18(3):374-375. Bianchi, A. Extracts of Monascusus purpureus beyond statins--profile of efficacy and safety of the use of extracts of Monascus purpureus. Chin J Integr.Med 2005;11(4):309-313. View abstract. Chen ZM. Comparison of the therapeutic effects of simvastatin and Zhibituo for treatment of hyperlipidemia. Guangxi Yike Daxue Xuebao 2001;18(4):543. Xu CB, Hu DY Kang LP Tian YW Gao MM Xu ZM Jin SY Ma FY Ma M Shi XY Zhang BH Long NZ Li L Xue L Zhang JH Chen XL Dai CX. Comparative study of relatively long-term therapy for dyslipidemia with low-dose Xuezhikang or pravastatin in Chinese patients. Zhongguo Yaoxue 2000;9(4):218-222. Cong B. Observations on the therapeutic effects of Zhibituo for treatment of hyperlipidemia. Hebei Yiyao 1999;5(3):60-61. Deng YM, Meng MK Liao YZ. Clinical observation of Xuezhikang on treatment of elderly patients with primary mixed hyperlipidemia. Chinese Journal of Gerontology 2006;26(11):1566-1567. Affuso, F. Ruvolo, A. Micillo norsk casino bonus gratuit, F. Sacca, L. and Fazio, S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc.Dis 2010;20(9):656-661. View abstract. Lapi F, Gallo E, Bernasconi S, et al. Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products. Br J Clin Pharmacol 2008;66:572-74. View abstract. Endo, A. and Kuroda, A. Citrinin, an inhibitor of cholesterol synthesis. J Antibiot (Tokyo) 1976;29(8):841-843. Zhang JS. Comparison of Xuezhikang and inositol nicotinate for treatment of hyperlipidemia. Zhiye Yu Jiankang 2002;18(1):138-140. Yu, P. Shen, Z. Chi casino bonus norge 5 inch, J. and Yang, C. Clinical observation of the effects of xuezhikang on older primary hyperlipidemia patients. Chinese Journal of Geriatrics 1996;16:206-208. Xiao M, Ye P. Clinical observation of Xuezhikang for treatment of hyperlipidemia. Shuli Yixue Zazhi 2001;14(3):244-245. Xu JM, Chen SX Hu WY Cai NS Xu Q Wu ZG Sun KX. Zhibituo vs. placebo treatment of hyperlipidemia a double blind randomized and multicenter study. Zhongguo Xinyao Yu Linchuang Zazhi 1997;16(1):47-51. Knecht, A. Cramer, B. and Humpf, H. U. New Monascus metabolites: structure elucidation and toxicological properties studied with immortalized human kidney epithelial cells. Mol Nutr Food Res 2006;50(3):314-321. View abstract. Bogsrud, M. P. Ose, L. Langslet, G. Ottestad, I. Strom, E. C. Hagve, T. A. and Retterstol, K. HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study. Scand.Cardiovasc.J. 2010;44(4):197-200. View abstract. Robbers JE, Tyler VE. Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press, 1999. Teng, S. S. and Feldheim, W. Anka and anka pigment production. J Ind Microbiol.Biotechnol 2001;26(5):280-282. View abstract. Chen ZL. Controlled study of Diao Zhibituo and alginic sodium diester for lipid lowering effect. Henan Shiyong Shenjingbing Zazhi 1998;1(2):20. Sun, M. Li, Y. and Yan, W. [Effect of monascus on improving the hemorheology of rats with high blood lipids]. Wei Sheng Yan.Jiu. 2001;30(3):173-175. View abstract. Knecht, A. and Humpf, H. U. Cytotoxic and antimitotic effects of N-containing Monascus metabolites studied using immortalized human kidney epithelial cells. Mol Nutr Food Res 2006;50(4-5):406-412. View abstract. Quan SL, Wang W Qu XW Chen J. Controlled observation on therapeutic effects of Xuezhikang and simvastatin for treatment of hypercholesterolemia. Zhonghua Shiyong Yixue 2003;3(5):427. Zheng Y, Luo XZ Wang SL Yang YJ. Clinical controlled study on the therapeutic effects of Xuezhikang and Simvastatin. Zhongguo Yaoshi 2001;36(10):715. Zhang QL. Comparative interventional therapies of dyslipidemia by simvastatin and Zhibituo with 60 cases. Guoji Yiyao Weisheng Daobao 2004;10(10):29-30. Endo, A. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot.(Tokyo) 1979;32(8):852-854. View abstract. Fan, X. F. Deng, Y. Q. Ye, L. Li, Y. D. Chen, J. Lu, W. W. and Li, J. P. Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia. Chin J.Integr.Med. 2010;16(2):119-123. View abstract. Lu, Z. Kou kasino paa nett tell, W. Qiu, Z. and et al. Clinical observation of xuezhikangon treatment of hyperlipidemia. Chinese Circulation Journal 1997;12(1):12-15. Kucsera, J. Pfeiffer, I. and Ferenczy, L. Homothallic life cycle in the diploid red yeast Xanthophyllomyces dendrorhous (Phaffia rhodozyma). Antonie Van Leeuwenhoek 1998;73(2):163-168. View abstract. Yang WJ, Fu XJ. Comparison of the therapeutic effects of Zhibituo and simvastatin for treatment of hyperlipidemia. Zhongguo Xiandai Yiyao Yu Jishu 2003;3(2):2-4. China Coronary Secondary Prevention Study Group. China coronary secondary prevention study (CCSPS). Lipid regulating therapy with xuezhikang for secondary prevention of coronary heart disease. Chin J Cardiol (Chin) 2005;33:109-115. Rippe J, Bonovich K, Colfer K, and et al. A multi-center, self-controlled study of Cholestin in subjects with elevated cholestrol. Abstracts of the 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention 1999;99:1123 (Abstract P88). Yang SS. Xuezhikang for treatment of 76 patients with hyperlipidemia. Zhongchengyao 2002;24(10):815-816. Li, J. J. Lu, Z. L. Kou, W. R. Chen, Z. Wu, Y. F. Yu, X. H. and Zhao, Y. C. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS). Clin Exp Hypertens 2010;32(8):491-498. View abstract. Kuramoto, Y. Yamada casino roulette tricks, K. Tsuruta, O. and Sugano, M. Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. Biosci.Biotechnol.Biochem. 1996;60(10):1712-1713. View abstract. Zhu WM, Wu SR. Effects and safety of combined treatment by Xuezhikang and micronized fenofibrate in patients with hyperlipidemia. Zhongguo Linchuang Yixue Zazhi 2003;4(2):18-20. Huang GZ, Yang S Wu ZG. Observation on therapuetic effect of Zhibituo for treatment of hyperlipidemia. Dier Junyi Daxue Xuebao 1998;19(1):94-95. Xu WY, Yan YZ Tang ZH. Therapeutic observations on Xuezhikang capsules for treatment of hyperlipidemia. Haixia Yaoxue 2003;15(2):65-66. Endo, A. Hasumi, K. Nakamura, T. Kunishima, M. and Masuda, M. Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis. J Antibiot.(Tokyo) 1985;38(3):321-327. View abstract. Li DX, Li YF Lu HY. Comparison of the effects of Xuezhikang with inositol hexanicotinate on lipid profile modification. Henan Zhigong Yixueyuan Xuebao 2000;12(1):17-18. Lei HZ. Effects of Xuezhikang on endothelial function in aged patients with hyperlipidemia. Guangxi Yixue 2004;26(4):495-497. Wang, W. H. Zhang, H. Yu, Y. L. Ge, Z. Xue, C. and Zhang, P. [Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24(12):1073-1076. View abstract. Li, Q. L. and Zhang, Y. F. [Clinical observation on effect of taizhi'an capsule in treating 150 patients with hyperlipidemia]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2003;23(5):335-337. View abstract. Wang YF, Yang CK Xu WJ Sun L Liu B Wang GG. Xuezhikang, gemfibrozil for regulation of hyperlipidemia in elderly and insulin sensitivity. Zhongguo Xinyao Zazhi 1998;7(3):209-211. Ye, P. Wu, C. E. Sheng, L. and Li, H. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension. J Altern Complement Med 2009;15(7):719-725. View abstract. Yasukawa, K. Takahashi, M. Natori european 9 point mount, S. Kawai, K. Yamazaki, M. Takeuchi, M. and Takido, M. Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology 1994;51(1):108-112. View abstract. Deng, J. Yun, L. and Peng, C. Clinical observations of xuezhikang on acute myocardial infarction patients with hyperlipoidemia. Journal of Capital Medicine 2000;7(1):42-43. Li BH, Zheng GJ Zhang WG Xu M Ren P. Clinical observations of Ruanmaijianzhi capsule in the treatment of dyslipidemia. Hebei Zhongyi Zazhi 2004;26(9):657-659. Ye, P. Wu, C. Sheng, L. and Li, H. Effect of xuezhikang on alpha1- and beta2-microglobulin in patients with essential hypertension. J.Hum.Hypertens. 2009;23(1):72-74. View abstract. Liu J, Zhang J, Shi Y, et al. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 2006;1:4. View abstract. Feuerstein, J. S. and Bjerke, W. S. Powdered red yeast rice and plant stanols and sterols to lower cholesterol. J.Diet.Suppl 2012;9(2):110-115. View abstract. Drouet, M. Le Sellin, J. Gay, G. el Founini, M. and Sabbah, A. [Allergy to Chenopodiaceae (beets, spinach) associated with latex allergy]. Allerg.Immunol.(Paris) 1994;26(3):113-114. View abstract. Li, J. J. Hu, S. S. Fang europeisk roulette table diagram, C. H. Hui, R. T. Miao, L. F. Yang online casino norge apartments, Y. J. and Gao, R. L. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina. Clin Chim.Acta 2005;352(1-2):217-224. View abstract. Lee, C. L. Tsai, T. Y. Wang, J. J. and Pan, T. M. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl.Microbiol.Biotechnol 2006;70(5):533-540. View abstract. Ye, P. Lu, Z. L. Du, B. M. Chen, Z. Wu, Y. F. Yu, X. H. and Zhao, Y. C. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study. J.Am.Geriatr.Soc. 2007;55(7):1015-1022. View abstract. Feng XY, Wang XF Li X. Analysis of 116 cases of hyperlipemia in treatment with Xuezhikang. Medical Information 2006;19(3):512-513. Zhao, S. P. Liu, L. Cheng, Y. C. and Li, Y. L. Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis 2003;168(2):375-380. View abstract. Zheng CJ, Wang P. Zhibituo vs. simvastatin in treatment of hyperlipidemia. Zhongguo Yaoshi 2001;4(6):447-448. Wild, D. Toth, G. and Humpf, H. U. New monascus metabolites with a pyridine structure in red fermented rice. J Agric.Food Chem 8-27-2003;51(18):5493-5496. View abstract. Chen LL, Liu J. The lipid regulation function of Xuezhikang on hypercholesterolemia. Herald of Medicine 2002;21(1):31-32. Havel, R. J. Hunninghake, D. B. Illingworth, D. R. Lees mobile lawn mower repair, R. S. Stein, E. A. Tobert, J. A. Bacon, S. R. Bolognese, J. A. Frost, P. H. Lamkin, G. E. and. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Ann.Intern.Med 1987;107(5):609-615. View abstract. Vercelli, L. Mongini, T. Olivero, N. Rodolico, C. Musumeci, O. and Palmucci, L. Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. J Am Geriatr Soc 2006;54(4):718-720. View abstract. Cheng XM, Yu ZM Luo HD Qiu YH Chen MX. Effect of Xuezhikang on endothelial function in patients with hyperlipidemia. Chin J Arterioscler 2001;9(3):235-237. Huang HN, Hua YY, Bao GR, Xie LH. The quantification of monacolin K in some red yeast rice from Fujian province and the comparison of the other product. Chem Pharm Bull (Tokyo) 2006;54:687-9. View abstract. Zhang GR. Comparison of Zhibituo and simvastatin for their effects on hyperlipidemia. Guangxi Yixue 2002;24(5):713-714. Guo WC, Feng WJ. Clinical observations of statin alone or combined with unsaturated fatty acids for the treatment of combined hyperlipidemia in elderly people. Beijing Yixue 2003;25(1):25-27. Kuno, N. and Mizutani, T. Influence of synthetic and natural food dyes on activities of CYP2A6, UGT1A6, and UGT2B7. J Toxicol.Environ Health A 8-27-2005;68(16):1431-1444. View abstract. Guo XM, Tu L Mi S. Comparison of the therapeutic effects of Zhibituo and simvastatin for regulating dyslipidemia. Zhongyao Yaoli Yu Linchuang 1999;15(6):46-48. Krejci, M. E. Bretz, N. S. and Koechel, D. A. Citrinin produces acute adverse changes in renal function and ultrastructure in pentobarbital-anesthetized dogs without concomitant reductions in [potassium] plasma. Toxicology 1-8-1996;106(1-3):167-177. View abstract. Heber D, Lembertas A roulette system justification, Lu QY, et al. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med 2001;7:133-9. View abstract. Liao, C. C. Huang, C. L. Su, K. P. Chang, Y. H. and Lin, C. C. Red Yeast Rice for a patient with olanzapine-induced dyslipidemia: a test-and-retest case report. Prog.Neuropsychopharmacol.Biol.Psychiatry 7-1-2008;32(5):1340-1341. View abstract. Wang CW, Gao FM You L. Clinical study on the therapeutic effects of Xuezhikang for treatment of hyperlipidemia. Mudanjiang Yixueyuan Xuebao 2000;21(3):13. Liu, X. D. Wang, M. and Li, Y. Z. [Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis]. Zhongguo Zhen.Jiu. 2010;30(8):637-641. View abstract. Yu HY, Li TH. Observations on the therapeutic effects of Zhibituo for treatment of hyperlipidemia. Xinxueguan Kangfu Yixue Zazhi 1999;8(1):30-31. Cicero, AF, Rovati LC, and Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittelforschung. 2007;57:26-30. View abstract. Wang, J. J. Shieh, M. J. Kuo, S. L. Lee, C. L. and Pan, T. M. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Appl.Microbiol.Biotechnol 2006;70(2):247-253. View abstract. Liu, Z. M. Li, Z. Zhang norsk online casino chip, H. and et al. The clinical observation of the medical treatment for hyperlipidemia with Xuezhikang. Unpublished data, reported by Institute for Natural Products Research (INPR) 2001; Huang YL, Zhou JG Zhang HF Shi YX Wang MS. Comparison of the therapeutic effects of simvastatin and Zhibituo for the elderly with hyperlipidemia. Yixue Yu Gongcheng 2001;3(1):24-27. Zheng H, Dan XY Ning H Xue B. Observations of Xuezhikang on clinical effects and haemorheology. Hebei Yiyao 2001;7(1):46-48. Li Y, Min YB Fan XJ. Comparison of the therapeutic effects of Zhibituo and fish oils for treatment of 30 cases of hyperlipidemia. Guangdong Yaoxue Zazhi 2000;10(1):43-45. Jin W, Yang H, Zhang C, et al. A COMPARATIVE STUDY OF XUEZHIKANG AND MEVALOTIN IN TREATMENT OF ESSENTIAL HYPERLIPIDEMIA. Chinese Journal of New Drugs 1997;6:265-268. Chen L, Qin YW Guo RB. Clinical efficacy of capsule Xuezhikang in treatment of hypercholesterolemia. Yaoxue Fuwu Yu Yanjiu 2002;2(1):39-40. Fang, Y. and Li, W. Effect of xuezhikang on lipid metabolism and Islet 3 cell function in type II diabetic patients. Journal of Capital Medicine 2000;7(2):44-45. Jeppesen, U. Gaist, D. Smith, T. and Sindrup, S. H. Statins and peripheral neuropathy. Eur.J Clin Pharmacol 1999;54(11):835-838. View abstract. Ma L, Gao Y Li BZ. Observations of the therapeutic effects of Zhibituo for treatment of 50 patients with hyperlipidemia. Xibei Yaoxue Zazhi 2000;15(3):126.
0 Comments
Leave a Reply. |